M. R. Hamblin, Ph.D. holder, is a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School, and a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his Ph.D. degree from Trent University in England. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and stimulation of the immune system and in low-level light therapy (LLLT) for wound healing, arthritis, traumatic brain injury, neurodegenerative diseases, and psychiatric disorders. He has published 284 peer-reviewed articles, over 150 conference proceedings, book chapters, and international abstracts and holds 8 patents. He is Associate Editor for 7 journals, on the Editorial Board of a further 12 journals, and serves on NIH Study Sections. For the past 10 years Dr. Hamblin has chaired an annual conference at SPIE Photonics West entitled Mechanisms for Low Level Light Therapy.
Biography Updated on 22 October 2015